Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK | REGN | ARGX | ||
| Company | Gsk Plc ADR | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 33.94 | 720.86 | 622.49 | ||
| High | 34.19 | 726.81 | 627.80 | ||
| Low | 33.84 | 711.92 | 615.82 | ||
| Last | 33.95 | 715.19 | 620.16 | ||
| Change | +0.13 | +2.86 | +5.16 | ||
| % Change | +0.38% | +0.40% | +0.84% | ||
| Volume | 1,999,100 | 479,100 | 142,700 | ||
| 20-Day Average Volume | 3,895,295 | 849,260 | 225,020 | ||
| Previous Close | 33.82 | 712.33 | 615.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 34.18 | 734.52 | 621.42 | ||
| 20-Day Raw Stochastic | 28.04% | 20.55% | 41.67% | ||
| 20-Day Relative Strength | 43.44% | 34.68% | 55.35% | ||
| Weighted Alpha | -18.57 | -31.13 | +63.75 | ||
| Today's Opinion | 100% Sell | 100% Sell | 88% Buy | ||
| Previous Opinion | 100% Sell | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Sell | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.24% since 12/24/24 | +0.10% since 12/24/24 | -1.56% since 12/24/24 | ||
| Low | 33.55 on 12/30/24 | 700.42 on 12/30/24 | 613.00 on 12/31/24 | ||
| High | 34.19 on 01/02/25 | 726.81 on 01/02/25 | 637.08 on 12/26/24 | ||
| 1-Month | |||||
| %Chg | -1.05% since 12/02/24 | -6.18% since 12/02/24 | +0.43% since 12/02/24 | ||
| Low | 33.04 on 12/20/24 | 693.00 on 12/19/24 | 602.44 on 12/13/24 | ||
| High | 36.28 on 12/09/24 | 800.99 on 12/09/24 | 644.97 on 12/17/24 | ||
| 3-Month | |||||
| %Chg | -13.94% since 10/02/24 | -31.25% since 10/02/24 | +12.76% since 10/02/24 | ||
| Low | 32.83 on 11/15/24 | 693.00 on 12/19/24 | 514.92 on 10/09/24 | ||
| High | 41.80 on 10/09/24 | 1,038.81 on 10/03/24 | 644.97 on 12/17/24 | ||
| 6-Month | |||||
| %Chg | -11.15% since 07/02/24 | -31.54% since 07/02/24 | +42.41% since 07/02/24 | ||
| Low | 32.83 on 11/15/24 | 693.00 on 12/19/24 | 432.96 on 07/08/24 | ||
| High | 44.67 on 08/27/24 | 1,211.20 on 08/27/24 | 644.97 on 12/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 70,093,640 | 78,277,936 | 37,126,320 | ||
| Shares Outstanding, K | 2,072,550 | 109,890 | 60,368 | ||
| Annual Sales | 37,725,000,000 | 13,117,200,000 | 1,268,590,000 | ||
| Annual Net Income | 6,129,940,000 | 3,953,600,000 | -295,050,000 | ||
| Last Quarter Sales | 10,420,410,000 | 3,720,700,000 | 588,880,000 | ||
| Last Quarter Net Income | -75,430,000 | 1,340,600,000 | 91,410,000 | ||
| 60-Month Beta | 0.64 | 0.08 | 0.59 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.27 on 10/30/24 | 12.46 on 10/31/24 | 1.39 on 10/31/24 | ||
| Latest Earnings Date | 01/29/25 | 02/07/25 | 10/31/24 | ||
| Most Recent Dividend | 0.382 on 11/15/24 | N/A | N/A | ||
| Next Ex-Dividends Date | 11/15/24 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 8.07 | 17.57 | 0.00 | ||